Key facts
- This page summarizes Debora Barton's Form 3 filing for TScan Therapeutics, Inc. (TCRX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2022, 07:54.
Debora Barton - 05 Jul 2022 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- TCRX
- Reported as of
- 05 Jul 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Jul 2022, 07:54:15 UTC
- Next SEC filing
- 06 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Debora Barton
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Debora Barton filed Form 3 for TScan Therapeutics, Inc. (TCRX) on 07 Jul 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.